• Pain: what have we learned from transgenic mice?
• Neurobiology of addiction
• Cytokine antagonists in rheumatoid arthritis
• Hypervigilance, attention, fear and catastrophising
• RTCs vs. real life clinical experience
• Contribution of non-neural cells to pain hypersensitivity
• Can pain trigger neurodegeneration and cognitive deficits?
• Peripheralized analgesics
• Genetics of individual differences in pain sensibility
• Painful peripheral neuropathies
• Changing the public's perception of pain
• Placebo and cognitive approaches to pain management
• Sex hormones and pain
• Changes in gene expression in neuropathy
• Efficacy of exercise and physiotherapy
• Pain pharmacogenetics
• Viscero-visceral and viscero-somatic interactions
• Evidence of efficacy in complementary and alternative medicine
• The science of rehabilitation medicine
• Clinical case discussions
• Managing low back pain and sciatica
• Public and professional pain education
• Pain assessment in the clinic vs. the laboratory
• Nurse prescribing in pain management
• Epidemiology of pain management in primary care
• Do neuropathic and non-neuropathic pain really differ?
• Optimizing drug combinations for pain management
• Diagnostic injections for chronic pain
• Invasive treatment for spinal pain
• Practice and ethics of end of life pain management
• Orofacial pain
• Chronic pain syndromes during pregnancy
• Pain paroxysms
• Pain control in cognitively impaired individuals
• Pediatric postoperative pain management
• Backpain, RSD and migraine in children
• Tolerance and sensitization in opioid therapy
• The philosophy and ethics of pain
• Impact of opioids on cognition and performance
• Headache and migraine
• Anti-convulsants for neuropathic pain and headache
• Stress and pain
• Managing central pain
• Attention, attention bias and secondary prevention
• Cues of pain and distress
• Visceral and cardiac pain
• Cancer pain